Learn More ResMed Inc (ASX: RMD) shares are in the red so far in 2025. After slipping from 52-week highs of $40.50 in January, shares in the respiratory device company currently fetch $35.71 apiece.

ResMed's fifth annual Global Sleep Survey highlights a significant global sleep crisis, revealing that 71% of employed individuals have called in sick at least once due to poor sleep, with the ...

Somnee Group International Inc (SGI) reported its financial results for the fourth quarter of 2024, surpassing earnings expectations. The company posted an adjusted earnings per share (EPS) of $0. ...

ResMed Inc.’s RMD adjusted earnings per share (EPS) in the second quarter of fiscal 2025 were $2.43, up 29.2% year over year. The metric beat the Zacks Consensus Estimate by 5.6%. The adjustments ...

ResMed outperformed market expectations in Q2, reporting a 10% revenue increase to $US1.3 billion and a 65% surge in net income to $US344.6 million.... "Lorem ipsum ...

ResMed's second-quarter results, released on January 30, 2025, demonstrated strong financial health, with a 10% year-over-year (YoY) increase in revenue and a significant improvement in gross ...